1 |
Kawagishi, H., M. Ando, K. Shinba, H. Sakamoto, S. Yoshida, F. Ojima, Y. Ishiguro, N. Ukai, and S. Furukawa (1993), Chromans, hericenones F, G and H from the mushroom Hericium erinaceum, Phytochemistry 32(1), 175-178
DOI
ScienceOn
|
2 |
Kawagishi , H., Shimada, A., Shiznki. K., Mori, H., Okamoto, K., Sakamoto, H., and S. Furukawa (1996), Erinacines D, a stimulator of nerve growth factor (NGF)- synthesis, from the mycelia of Hericium erinaceum, Heterocycl. Commun. 2(1), 51-54
|
3 |
Chemnitis , J. M., K. H. Haselmeye, B. D. Gonska, H. Kreuzer, and R. Zech (1996), Indirect parasympathomimetic activity of metoclopramide: reversible inhibition of cholinesterases from human central nervous system and blood, Pharmacol. Res. 34, 65-72
DOI
ScienceOn
|
4 |
Wanda, J. K., J. S. John, and R. C. Neal (1999), Cholinesterase inhibitors: a therapeutic strategy for Alzheimer's disease, Ann. Pharmacother. 33, 441-450
DOI
ScienceOn
|
5 |
Sayre, L. M., D. A. Zelasko, and P. L. R. Harris (1997), 4-hydroxynonenal- derived advanced lipid peroxidation end products are increased in Alzheimer's disease, J. Neurochem. 68, 2092-2097
DOI
ScienceOn
|
6 |
Gwebu, E. T., M. Selassie, N. T. Gwebu, S. Richardson, D. Mathis, J. William, and J. Waden (1997), Cytotoxicity of on vascular muscle cells and attenuation by vitamin E. In Vitro Cell, Dev. BioI. Anim. 33, 672-673
DOI
ScienceOn
|
7 |
Giacobini, E. (1997), From molecular Structure to Alzheimer therapy, Jpn, J. Pharmacol. 74, 225-241
DOI
|
8 |
Blois, M. S. (1958), Antioxidant determinations by the use of a stable free radical, Nature 181, 1199-1202
DOI
ScienceOn
|
9 |
Markesbery, M. R. and M. A. Lovell (1998), Four-hydroxynonenal, a product of lipid peroxidation, is increased in Alzheimer's disease, NurobioI. Aging. 19, 33-36
DOI
ScienceOn
|
10 |
SAS (1988), Statistical Analysis System, Property software (Release 6.03 ed.). SAS Institute Inc., Cary, NC, USA
|
11 |
Du, Z. and W. J. Bramlage (1992), Modified thiobarbituric acid assay for measuring lipid oxidation in sugar-rich plant tissue extracts, J. Agric. Food Chem. 40, 1566-1570
DOI
|
12 |
Kawagishi , H., A. Shimada, R. Shirai, K. Okamoto, F Ojiima, H. Sakamoto, Y. Ishiguro, and S. Furukawa (1994), Erinacines A, B and C, strong stimulators of nerve growth factor (NGF)-synthesis, from the mycelia of Hericium erinaceum, Tetrahedron Letter 35(10), 1569-1572
DOI
ScienceOn
|
13 |
Younkin , S. G., B. Goodridge, J. Katz, G . Lockett, D. Nafziger, M. F. Usiak, and L. H. Younkin (1986), Molecular forms of acetylcholinesterases in Alzheimer's disease, Fed. Proc. 45, 2980-2988
|
14 |
Gasparin, L., M. Rasshi, G. Binetti, M. Trabucchi, S. B. Solerte, D. Alkon, R. Ercheberrigary, G. Gibson, J. Blass, R. Paoletti, and S. Govoin (1998), Peripheral markers in testing pathophysiological hypothesis and diagnosing Alzheimer's disease, FASEB J. 12, 17-34
DOI
|
15 |
Ellman, G. L., K. D. Coutuney, V. Andres, and R. M. Featherstone (1961), A new and rapid colorimetric determination of acetylcholinesterase activity, Biochem. Pharmacol. 7, 88-95
DOI
ScienceOn
|
16 |
Kopal, T., R. Subramanian, J. Drake, and R. Prasad (1998), Vitamin E protects against Alzheimer's amyloid peptide(25-35) induced changes in neocortical snaptosomal membrane lipid structure and composition, Brain Res. 786, 270-273
DOI
|
17 |
Tsakiris, S. and K. H. Schulpis (2002), Alanine reverses the inhibitory effect of phenylalanine on acetylcholinesterase activity, Z. Naturforsch 57c, 506-511
|
18 |
Hugo, L. H., D. M. Richardo, and C. L. Nibaldo (1996), Tetrameric(G4) acetyl- cholinesterase: structure, localization, and physiological regulation, J. Neurochem. 66, 1335-1346
DOI
|
19 |
Osawa, T. and M. Namiki (1981), A novel type of antioxidant isolated from leaf wax of Eucalyptus leaves, Agric. BioI. Chem. 45(3), 735-739
DOI
|
20 |
Segel, I. H. (1975), Enzyme Kinetics, A Wiley-Interscience Publication, New York, pp.100-160, 161-226
|
21 |
Kasuga, A., Y. Aoyagi, and K. Sugahara (1993), Antioxidative activities of sevral mushroom extracts, Nippon Shokuhin Kogyo Gakkaishi 40(1), 56-63
DOI
ScienceOn
|
22 |
Furukawa, S. and H. Kawagishi (1991), Physiological significance and the synrhesis-prmoting substances of nerve growth factor (NGF), Chemistry & Biology 29(10), 640-646
|
23 |
Kawagishi, H., Shimada, A., Hosokawa, S., Mori, H., Sakamoto, H., Ishiguro, Y., Sukemi, S., J. Bordner, N. Kojima, and S. Furukawa (1996), Erinacines E, F and G, stimulators of nerve growth facror(NGF)-synthesis, from the mycelia of Hericium erinaceum, Tetrahedron Letter 37(41), 7399-7402
DOI
ScienceOn
|
24 |
Brufani, M., L. Filocamo, S. Lappa, and A. Maggi (1997), New acetyl- cholinesterase inhibitors, Drugs Future 22, 397-411
|